ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

ABVC ABVC BioPharma Inc

1.09
0.01 (0.93%)
07 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
ABVC BioPharma Inc ABVC 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.01 0.93% 1.09 09:00:00
개장가 저가 고가 종가 전일 종가
1.09 1.0309 1.09 1.09 1.08
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
18/04/202422:25GLOBEAiBtl BioPharma Inc. Acquired TT Life Company, Valued at..
17/04/202422:00GLOBEABVC BioPharma Executes a Global Licensing Definitive..
10/04/202421:30GLOBEABVC BioPharma Executes a Global Licensing Term Sheet for..
26/03/202421:30GLOBEABVC BioPharma Entered into a Global Licensing Deal of..
21/03/202421:30GLOBEAiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging..
19/03/202421:30GLOBEABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO..
14/03/202422:30GLOBEABVC BioPharma Reports Annual 2023 Financials and Provides..
01/03/202406:32EDGAR2Form 8-K/A - Current report: [Amend]
01/03/202406:31EDGAR2Form 8-K/A - Current report: [Amend]
27/02/202422:30GLOBEABVC's New Horizon for Oncology and Hematology Aims at..
17/02/202407:04EDGAR2Form S-1/A - General form for registration of securities..
15/02/202422:30GLOBEABVC BioPharma Executes a Definitive Agreement to Receive..
14/02/202409:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/02/202422:30GLOBEABVC BioPharma Receives Australian Patent, Valid Until 2040,..
10/02/202407:04EDGAR2Form S-1/A - General form for registration of securities..
08/02/202423:30EDGAR2Form 8-K - Current report
08/02/202423:17GLOBEABVC Acquires $2.96 Million Worth of Land in Asia with..
18/01/202407:01EDGAR2Form 8-K/A - Current report: [Amend]
18/01/202407:00EDGAR2Form 8-K - Current report
18/01/202406:30EDGAR2Form 8-K - Current report
13/01/202407:01EDGAR2Form S-1 - General form for registration of securities under..
03/01/202421:24GLOBEABVC BioPharma and its Subsidiary Receive $460M From AiBtl..
07/12/202322:30GLOBEABVC BioPharma Announces Completion of Subject Treatment for..
05/12/202322:30GLOBEABVC BioPharma Shares Insights from Dr. Scott Irwin of..
21/11/202322:30GLOBEABVC BioPharma Receives U.S. Patent for ADHD Treatment, a..
20/11/202322:30EDGAR2Form 8-K - Current report
18/11/202307:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
18/11/202307:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
17/11/202300:05GLOBEABVC BioPharma Enters Definitive Agreement with Licensing..
16/11/202323:20EDGAR2Form 8-K - Current report
15/11/202323:00GLOBEABVC BioPharma Reports Third Quarter 2023 Financial and..
15/11/202322:41EDGAR2Form 8-K - Current report
15/11/202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202321:30GLOBEABVC BioPharma Entered Into a Term Sheet to License Global..
17/10/202321:30GLOBEABVC BioPharma Announces Completion of Subject Recruitment..
09/10/202321:30GLOBEABVC BioPharma Receives Taiwanese Patent for Its Treatment..
13/09/202322:01EDGAR2Form 8-K - Current report
06/09/202321:30EDGAR2Form 8-K/A - Current report: [Amend]
31/08/202321:30EDGAR2Form 8-K - Current report
23/08/202321:30GLOBEABVC BioPharma Provides Updates on ADHD Phase IIb Clinical..
18/08/202306:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
18/08/202306:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
17/08/202322:19GLOBEABVC Executes Cooperation Agreement for Strategic..
17/08/202321:33EDGAR2Form 8-K - Current report
15/08/202305:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202321:30GLOBEABVC BioPharma Regains Compliance With Nasdaq's Minimum Bid..
10/08/202306:00EDGAR2Form 8-K/A - Current report: [Amend]
08/08/202305:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/08/202321:30GLOBEABVC Corporate Update and CEO's Letter to Shareholders
07/08/202321:00EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock